249 related articles for article (PubMed ID: 28137276)
1. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
[TBL] [Abstract][Full Text] [Related]
2. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
[TBL] [Abstract][Full Text] [Related]
3. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
4. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.
Do H; Wong SQ; Li J; Dobrovic A
Clin Chem; 2013 Sep; 59(9):1376-83. PubMed ID: 23649127
[TBL] [Abstract][Full Text] [Related]
5. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
7. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
[TBL] [Abstract][Full Text] [Related]
8. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
[TBL] [Abstract][Full Text] [Related]
9. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
[TBL] [Abstract][Full Text] [Related]
12. Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing.
Nagahashi M; Shimada Y; Ichikawa H; Nakagawa S; Sato N; Kaneko K; Homma K; Kawasaki T; Kodama K; Lyle S; Takabe K; Wakai T
J Surg Res; 2017 Dec; 220():125-132. PubMed ID: 29180174
[TBL] [Abstract][Full Text] [Related]
13. Generating Exome Enriched Sequencing Libraries from Formalin-Fixed, Paraffin-Embedded Tissue DNA for Next-Generation Sequencing.
Marosy BA; Craig BD; Hetrick KN; Witmer PD; Ling H; Griffith SM; Myers B; Ostrander EA; Stanford JL; Brody LC; Doheny KF
Curr Protoc Hum Genet; 2017 Jan; 92():18.10.1-18.10.25. PubMed ID: 28075488
[TBL] [Abstract][Full Text] [Related]
14. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
15. Performance of non-formalin fixed paraffin embedded samples in hybrid capture and amplicon next-generation sequencing panels.
Meireles SI; Cruz MV; de Godoy CD; de Testagrossa L
Diagn Cytopathol; 2024 Mar; 52(3):171-182. PubMed ID: 38124281
[TBL] [Abstract][Full Text] [Related]
16. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.
Wong SQ; Li J; Tan AY; Vedururu R; Pang JM; Do H; Ellul J; Doig K; Bell A; MacArthur GA; Fox SB; Thomas DM; Fellowes A; Parisot JP; Dobrovic A;
BMC Med Genomics; 2014 May; 7():23. PubMed ID: 24885028
[TBL] [Abstract][Full Text] [Related]
17. Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia.
Madsen MB; Kiss K; Cilius Nielsen F; Bennedbæk FN; Rossing M
Front Endocrinol (Lausanne); 2020; 11():146. PubMed ID: 32265839
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
19. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
[TBL] [Abstract][Full Text] [Related]
20. Alternative Tissue Fixation Protocols Dramatically Reduce the Impact of DNA Artifacts, Unraveling the Interpretation of Clinical Comprehensive Genomic Profiling.
Berrino E; Bellomo SE; Chesta A; Detillo P; Bragoni A; Gagliardi A; Naccarati A; Cereda M; Witel G; Sapino A; Bussolati B; Bussolati G; Marchiò C
Lab Invest; 2024 Jan; 104(1):100280. PubMed ID: 38345263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
